Atacand (candesartan cilexetil) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
February 2016
WARNINGS AND PRECAUTIONS
Hyperkalemia
Concomitant use of ATACAND with drugs that may increase potassium levels may...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology | Warnings